nach oben

Translational Stroke Research

Erschienen in:

01.06.2014 | Original Article

Vascular Neural Network Phenotypic Transformation After Traumatic Injury: Potential Role in Long-Term Sequelae

verfasst von: J. Badaut, G. J. Bix

Erschienen in: Translational Stroke Research | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

The classical neurovascular unit (NVU), composed primarily of endothelium, astrocytes, and neurons, could be expanded to include smooth muscle and perivascular nerves present in both the up- and downstream feeding blood vessels (arteries and veins). The extended NVU, which can be defined as the vascular neural network (VNN), may represent a new physiological unit to consider for therapeutic development in stroke, traumatic brain injury, and other brain disorders (Zhang et al., Nat Rev Neurol 8(12):711–716, 2012). This review is focused on traumatic brain injury and resultant post-traumatic changes in cerebral blood flow, smooth muscle cells, matrix, blood–brain barrier structures and function, and the association of these changes with cognitive outcomes as described in clinical and experimental reports. We suggest that studies characterizing TBI outcomes should increase their focus on changes to the VNN, as this may yield meaningful therapeutic targets to resolve posttraumatic dysfunction.

Zhang JH, Badaut J, Tang J, Obenaus A, Hartman R, Pearce WJ. The vascular neural network—a new paradigm in stroke pathophysiology. Nat Rev Neurol. 2012;8(12):711–6. doi:10.1038/nrneurol.2012.210.PubMedCentralPubMed

Coronado VG, Xu L, Basavaraju SV, McGuire LC, Wald MM, Faul MD, et al. Surveillance for traumatic brain injury-related deaths—United States, 1997–2007. MMWR Surveill Summ. 2011;60(5):1–32.PubMed

Thurman D, Guerrero J. Trends in hospitalization associated with traumatic brain injury. JAMA. 1999;282(10):954–7.PubMed

Pop V, Badaut J. A neurovascular perspective for long-term changes after brain trauma. Transl Stroke Res. 2011;2(4):533–45. doi:10.1007/s12975-011-0126-9.PubMedCentralPubMed

Smith DH, Uryu K, Saatman KE, Trojanowski JQ, McIntosh TK. Protein accumulation in traumatic brain injury. Neuromol Med. 2003;4(1–2):59–72. doi:10.1385/NMM:4:1-2:59.

Gavett BE, Stern RA, Cantu RC, Nowinski CJ, McKee AC. Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimers Res Ther. 2010;2(3):18. doi:10.1186/alzrt42.PubMedCentralPubMed

Johnson VE, Stewart W, Smith DH. Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer’s disease? Nat Rev Neurosci. 2010;11(5):361–70. doi:10.1038/nrn2808.PubMedCentralPubMed

Ponsford J, Willmott C, Rothwell A, Cameron P, Ayton G, Nelms R, et al. Cognitive and behavioral outcome following mild traumatic head injury in children. J Head Trauma Rehabil. 1999;14(4):360–72.PubMed

Ponsford J, Willmott C, Rothwell A, Cameron P, Ayton G, Nelms R, et al. Impact of early intervention on outcome after mild traumatic brain injury in children. Pediatrics. 2001;108(6):1297–303.PubMed

10.

Ponsford J, Cameron P, Fitzgerald M, Grant M, Mikocka-Walus A. Long-term outcomes after uncomplicated mild traumatic brain injury: a comparison with trauma controls. J Neurotrauma. 2011;28(6):937–46. doi:10.1089/neu.2010.1516.PubMed

11.

Lippert-Gruner M, Kuchta J, Hellmich M, Klug N. Neurobehavioural deficits after severe traumatic brain injury (TBI). Brain Inj. 2006;20(6):569–74. doi:10.1080/02699050600664467.PubMed

12.

Babikian T, Satz P, Zaucha K, Light R, Lewis RS, Asarnow RF. The UCLA longitudinal study of neurocognitive outcomes following mild pediatric traumatic brain injury. J Int Neuropsychol Soc. 2011;17:886–95. doi:10.1017/S1355617711000907.

13.

Kuppermann N, Holmes JF, Dayan PS, Hoyle Jr JD, Atabaki SM, Holubkov R, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet. 2009;374(9696):1160–70. doi:10.1016/S0140-6736(09)61558-0.PubMed

14.

Schneier AJ, Shields BJ, Hostetler SG, Xiang H, Smith GA. Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States. Pediatrics. 2006;118(2):483–92.PubMed

15.

Brown AW, Leibson CL, Malec JF, Perkins PK, Diehl NN, Larson DR. Long-term survival after traumatic brain injury: a population-based analysis. NeuroRehabilitation. 2004;19(1):37–43.PubMed

16.

Harrison-Felix C, Whiteneck G, DeVivo M, Hammond FM, Jha A. Mortality following rehabilitation in the traumatic brain injury model systems of care. NeuroRehabilitation. 2004;19(1):45–54.PubMed

17.

Himanen L, Portin R, Hamalainen P, Hurme S, Hiekkanen H, Tenovuo O. Risk factors for reduced survival after traumatic brain injury: a 30-year follow-up study. Brain Inj. 2011;25(5):443–52. doi:10.3109/02699052.2011.556580.PubMed

18.

McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol. 2009;68(7):709–35. doi:10.1097/NEN.0b013e3181a9d503.PubMedCentralPubMed

19.

Fujita M, Wei EP, Povlishock JT. Intensity- and interval-specific repetitive traumatic brain injury can evoke both axonal and microvascular damage. J Neurotrauma. 2012;29(12):2172–80. doi:10.1089/neu.2012.2357.PubMedCentralPubMed

20.

Hart Jr J, Kraut MA, Womack KB, Strain J, Didehbani N, Bartz E, et al. Neuroimaging of cognitive dysfunction and depression in aging retired National Football League players: a cross-sectional study. JAMA Neurol. 2013;70(3):326–35. doi:10.1001/2013.jamaneurol.340.PubMedCentralPubMed

21.

Gardner A, Iverson GL, Stanwell P. A systematic review of proton magnetic resonance spectroscopy in sport-related concussion. J Neurotrauma. 2013. doi:10.1089/neu.2013.3079.PubMed

22.

Gardner A, Iverson GL, McCrory P. Chronic traumatic encephalopathy in sport: a systematic review. Br J Sports Med. 2013. doi:10.1136/bjsports-2013-092646.

23.

Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology. 1993;7(3):273–95.

24.

Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, et al. Alzheimer’s pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol. 2004;190(1):192–203. doi:10.1016/j.expneurol.2004.06.011.PubMed

25.

DeKosky ST, Abrahamson EE, Ciallella JR, Paljug WR, Wisniewski SR, Clark RS, et al. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch Neurol. 2007;64(4):541–4. doi:10.1001/archneur.64.4.541.PubMed

26.

Levine B, Kovacevic N, Nica EI, Cheung G, Gao F, Schwartz ML, et al. The Toronto traumatic brain injury study: injury severity and quantified MRI. Neurology. 2008;70(10):771–8. doi:10.1212/01.wnl.0000304108.32283.aa.PubMed

27.

Ragan DK, McKinstry R, Benzinger T, Leonard J, Pineda JA. Depression of whole-brain oxygen extraction fraction is associated with poor outcome in pediatric traumatic brain injury. Pediatr Res. 2012;71(2):199–204. doi:10.1038/pr.2011.31.PubMedCentralPubMed

28.

Cohen Z, Bonvento G, Lacombe P, Hamel E. Serotonin in the regulation of brain microcirculation. Prog Neurobiol. 1996;50(4):335–62.PubMed

29.

Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol. 2006;100(3):1059–64. doi:10.1152/japplphysiol.00954.2005.PubMed

30.

Cauli B, Hamel E. Revisiting the role of neurons in neurovascular coupling. Front Neuroenerg. 2010;2:9. doi:10.3389/fnene.2010.00009.

31.

Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci. 2006;7(1):41–53.PubMed

32.

Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood–brain barrier. Neurobiol Dis. 2010;37(1):13–25. doi:10.1016/j.nbd.2009.07.030.PubMed

33.

Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, Stopa EG, et al. Amyloid efflux transporter expression at the blood–brain barrier declines in normal aging. J Neuropathol Exp Neurol. 2010;69(10):1034–43. doi:10.1097/NEN.0b013e3181f46e25.PubMed

34.

Silverberg GD, Miller MC, Machan JT, Johanson CE, Caralopoulos IN, Pascale CL, et al. Amyloid and Tau accumulate in the brains of aged hydrocephalic rats. Brain Res. 2010;1317:286–96. doi:10.1016/j.brainres.2009.12.065.PubMed

35.

Ge S, Song L, Pachter JS. Where is the blood–brain barrier … really? J Neurosci Res. 2005;79(4):421–7. doi:10.1002/jnr.20313.PubMed

36.

Virgintino D, Robertson D, Errede M, Benagiano V, Tauer U, Roncali L, et al. Expression of caveolin-1 in human brain microvessels. Neuroscience. 2002;115(1):145–52.PubMed

37.

Vogelgesang S, Warzok RW, Cascorbi I, Kunert-Keil C, Schroeder E, Kroemer HK, et al. The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer’s disease. Curr Alzheimer Res. 2004;1(2):121–5.PubMedCentralPubMed

38.

Ruderisch N, Virgintino D, Makrides V, Verrey F. Differential axial localization along the mouse brain vascular tree of luminal sodium-dependent glutamine transporters Snat1 and Snat3. J Cereb Blood Flow Metab. 2011;31(7):1637–47. doi:10.1038/jcbfm.2011.21.PubMedCentralPubMed

39.

Saubamea B, Cochois-Guegan V, Cisternino S, Scherrmann JM. Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression. J Cereb Blood Flow Metab. 2012;32(1):81–92. doi:10.1038/jcbfm.2011.109.PubMedCentralPubMed

40.

Badaut J, Nehlig A, Verbavatz J, Stoeckel M, Freund-Mercier MJ, Lasbennes F. Hypervascularization in the magnocellular nuclei of the rat hypothalamus: relationship with the distribution of aquaporin-4 and markers of energy metabolism. J Neuroendocrinol. 2000;12(10):960–9.PubMed

41.

del Zoppo GJ, Milner R. Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol. 2006;26(9):1966–75. doi:10.1161/01.ATV.0000232525.65682.a2.PubMed

42.

Baeten KM, Akassoglou K. Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke. Dev Neurobiol. 2011;71(11):1018–39. doi:10.1002/dneu.20954.PubMedCentralPubMed

43.

Berardi N, Pizzorusso T, Maffei L. Extracellular matrix and visual cortical plasticity: freeing the synapse. Neuron. 2004;44(6):905–8. doi:10.1016/j.neuron.2004.12.008.PubMed

44.

Dityatev A, Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat Rev Neurosci. 2003;4(6):456–68. doi:10.1038/nrn1115.PubMed

45.

Milner R, Campbell IL. Developmental regulation of beta1 integrins during angiogenesis in the central nervous system. Mol Cell Neurosci. 2002;20(4):616–26.PubMed

46.

Owens T, Bechmann I, Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol. 2008;67(12):1113–21. doi:10.1097/NEN.0b013e31818f9ca8.PubMed

47.

Kim YS, Kim SS, Cho JJ, Choi DH, Hwang O, Shin DH, et al. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J Neurosci. 2005;25(14):3701–11. doi:10.1523/JNEUROSCI.4346-04.2005.PubMed

48.

Rafols JA, Kreipke CW, Petrov T. Alterations in cerebral cortex microvessels and the microcirculation in a rat model of traumatic brain injury: a correlative EM and laser Doppler flowmetry study. Neurol Res. 2007;29(4):339–47. doi:10.1179/016164107X204648.PubMed

49.

Badaut J, Moro V, Seylaz J, Lasbennes F. Distribution of muscarinic receptors on the endothelium of cortical vessels in the rat brain. Brain Res. 1997;778(1):25–33.PubMed

50.

Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74:13–40. doi:10.1146/annurev-physiol-012110-142315.PubMed

51.

Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–8. doi:10.1161/CIRCULATIONAHA.105.537878.PubMed

52.

Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. 2009;89(3):957–89. doi:10.1152/physrev.00041.2008.PubMedCentralPubMed

53.

Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, et al. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998;393(6682):276–80. doi:10.1038/30522.PubMed

54.

Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75(3):487–517.PubMed

55.

Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J Mon J Neth Soc Cardiol Neth Heart Found. 2007;15(3):100–8.

56.

Hubbell MC, Semotiuk AJ, Thorpe RB, Adeoye OO, Butler SM, Williams JM, et al. Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries. Am J Physiol. 2012;303:C1090–103.

57.

Baethmann A, Maier-Hauff K, Kempski O, Unterberg A, Wahl M, Schurer L. Mediators of brain edema and secondary brain damage. Crit Care Med. 1988;16(10):972–8.PubMed

58.

Sahuquillo J, Poca MA, Amoros S. Current aspects of pathophysiology and cell dysfunction after severe head injury. Curr Pharm Des. 2001;7(15):1475–503.PubMed

59.

Gaetz M. The neurophysiology of brain injury. Clin Neurophysiol. 2004;115(1):4–18.PubMed

60.

Zweckberger K, Eros C, Zimmermann R, Kim SW, Engel D, Plesnila N. Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice. J Neurotrauma. 2006;23(7):1083–93. doi:10.1089/neu.2006.23.1083.PubMed

61.

Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99(1):4–9. doi:10.1093/bja/aem131.PubMed

62.

Bouma GJ, Muizelaar JP, Choi SC, Newlon PG, Young HF. Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia. J Neurosurg. 1991;75(5):685–93. doi:10.3171/jns.1991.75.5.0685.PubMed

63.

Bryan Jr RM, Cherian L, Robertson C. Regional cerebral blood flow after controlled cortical impact injury in rats. Anesth Analg. 1995;80(4):687–95.PubMed

64.

Engel DC, Mies G, Terpolilli NA, Trabold R, Loch A, De Zeeuw CI, et al. Changes of cerebral blood flow during the secondary expansion of a cortical contusion assessed by 14C-iodoantipyrine autoradiography in mice using a non-invasive protocol. J Neurotrauma. 2008;25(7):739–53. doi:10.1089/neu.2007.0480.PubMed

65.

Kochanek PM, Marion DW, Zhang W, Schiding JK, White M, Palmer AM, et al. Severe controlled cortical impact in rats: assessment of cerebral edema, blood flow, and contusion volume. J Neurotrauma. 1995;12(6):1015–25.PubMed

66.

Schroder ML, Muizelaar JP, Bullock MR, Salvant JB, Povlishock JT. Focal ischemia due to traumatic contusions documented by stable xenon-CT and ultrastructural studies. J Neurosurg. 1995;82(6):966–71. doi:10.3171/jns.1995.82.6.0966.PubMed

67.

Alford PW, Dabiri BE, Goss JA, Hemphill MA, Brigham MD, Parker KK. Blast-induced phenotypic switching in cerebral vasospasm. Proc Natl Acad Sci U S A. 2011;108(31):12705–10. doi:10.1073/pnas.1105860108.PubMedCentralPubMed

68.

Sahuquillo J, Munar F, Baguena M, Poca MA, Pedraza S, Rodriguez-Baeza A. Evaluation of cerebrovascular CO₂-reactivity and autoregulation in patients with post-traumatic diffuse brain swelling (diffuse injury III). Acta Neurochir Suppl. 1998;71:233–6.PubMed

69.

Vavilala MS, Muangman S, Tontisirin N, Fisk D, Roscigno C, Mitchell P, et al. Impaired cerebral autoregulation and 6-month outcome in children with severe traumatic brain injury: preliminary findings. Dev Neurosci. 2006;28(4–5):348–53. doi:10.1159/000094161.PubMed

70.

Muizelaar JP. The use of electroencephalography and brain protection during operation for basilar aneurysms. Neurosurgery. 1989;25(6):899–903.PubMed

71.

Muizelaar JP, Ward JD, Marmarou A, Newlon PG, Wachi A. Cerebral blood flow and metabolism in severely head-injured children. Part 2: autoregulation. J Neurosurg. 1989;71(1):72–6.PubMed

72.

Freeman SS, Udomphorn Y, Armstead WM, Fisk DM, Vavilala MS. Young age as a risk factor for impaired cerebral autoregulation after moderate to severe pediatric traumatic brain injury. Anesthesiology. 2008;108(4):588–95. doi:10.1097/ALN.0b013e31816725d7.PubMed

73.

Sharples PM, Stuart AG, Matthews DS, Aynsley-Green A, Eyre JA. Cerebral blood flow and metabolism in children with severe head injury. Part 1: relation to age, Glasgow coma score, outcome, intracranial pressure, and time after injury. J Neurol Neurosurg Psychiatry. 1995;58(2):145–52.PubMedCentralPubMed

74.

Sharples PM, Matthews DS, Eyre JA. Cerebral blood flow and metabolism in children with severe head injuries. Part 2: cerebrovascular resistance and its determinants. J Neurol Neurosurg Psychiatry. 1995;58(2):153–9.PubMedCentralPubMed

75.

Armstead WM. Cerebral hemodynamics after traumatic brain injury of immature brain. Exp Toxicol Pathol. 1999;51(2):137–42.PubMed

76.

Ashwal S, Holshouser BA, Shu SK, Simmons PL, Perkin RM, Tomasi LG, et al. Predictive value of proton magnetic resonance spectroscopy in pediatric closed head injury. Pediatr Neurol. 2000;23(2):114–25.PubMed

77.

Bartnik BL, Sutton RL, Fukushima M, Harris NG, Hovda DA, Lee SM. Upregulation of pentose phosphate pathway and preservation of tricarboxylic acid cycle flux after experimental brain injury. J Neurotrauma. 2005;22(10):1052–65. doi:10.1089/neu.2005.22.1052.PubMed

78.

Casey PA, McKenna MC, Fiskum G, Saraswati M, Robertson CL. Early and sustained alterations in cerebral metabolism after traumatic brain injury in immature rats. J Neurotrauma. 2008;25(6):603–14. doi:10.1089/neu.2007.0481.PubMedCentralPubMed

79.

Ashwal S, Holshouser B, Tong K, Serna T, Osterdock R, Gross M, et al. Proton MR spectroscopy detected glutamate/glutamine is increased in children with traumatic brain injury. J Neurotrauma. 2004;21(11):1539–52.PubMed

80.

Armstead WM. Age-dependent impairment of K(ATP) channel function following brain injury. J Neurotrauma. 1999;16(5):391–402.PubMed

81.

Wada K, Chatzipanteli K, Busto R, Dietrich WD. Role of nitric oxide in traumatic brain injury in the rat. J Neurosurg. 1998;89(5):807–18. doi:10.3171/jns.1998.89.5.0807.PubMed

82.

Cherian L, Hlatky R, Robertson CS. Nitric oxide in traumatic brain injury. Brain Pathol. 2004;14(2):195–201.PubMed

83.

Armstead WM, Raghupathi R. Endothelin and the neurovascular unit in pediatric traumatic brain injury. Neurol Res. 2011;33(2):127–32. doi:10.1179/016164111X12881719352138.PubMedCentralPubMed

84.

Hall ED, Wang JA, Miller DM. Relationship of nitric oxide synthase induction to peroxynitrite-mediated oxidative damage during the first week after experimental traumatic brain injury. Exp Neurol. 2012;238(2):176–82. doi:10.1016/j.expneurol.2012.08.024.PubMedCentralPubMed

85.

Hlatky R, Lui H, Cherian L, Goodman JC, O’Brien WE, Contant CF, et al. The role of endothelial nitric oxide synthase in the cerebral hemodynamics after controlled cortical impact injury in mice. J Neurotrauma. 2003;20(10):995–1006. doi:10.1089/089771503770195849.PubMed

86.

Cherian L, Chacko G, Goodman C, Robertson CS. Neuroprotective effects of L-arginine administration after cortical impact injury in rats: dose response and time window. J Pharmacol Exp Ther. 2003;304(2):617–23. doi:10.1124/jpet.102.043430.PubMed

87.

Orihara Y, Ikematsu K, Tsuda R, Nakasono I. Induction of nitric oxide synthase by traumatic brain injury. Forensic Sci Int. 2001;123(2–3):142–9.PubMed

88.

Steiner J, Rafols D, Park HK, Katar MS, Rafols JA, Petrov T. Attenuation of iNOS mRNA exacerbates hypoperfusion and upregulates endothelin-1 expression in hippocampus and cortex after brain trauma. Nitric Oxide. 2004;10(3):162–9. doi:10.1016/j.niox.2004.03.005.PubMed

89.

Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A. 1997;94(13):6954–8.PubMedCentralPubMed

90.

Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca²⁺/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem. 1998;273(40):25804–8.PubMed

91.

Guix FX, Uribesalgo I, Coma M, Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol. 2005;76(2):126–52. doi:10.1016/j.pneurobio.2005.06.001.PubMed

92.

Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, et al. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood–brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem. 2011. doi:10.1111/j.1471-4159.2011.07542.x.

93.

Dore-Duffy P, Wang S, Mehedi A, Katyshev V, Cleary K, Tapper A, et al. Pericyte-mediated vasoconstriction underlies TBI-induced hypoperfusion. Neurol Res. 2011;33(2):176–86. doi:10.1179/016164111X12881719352372.PubMed

94.

Kreipke CW, Rafols JA. Calponin control of cerebrovascular reactivity: therapeutic implications in brain trauma. J Cell Mol Med. 2009;13(2):262–9. doi:10.1111/j.1582-4934.2008.00508.x.PubMed

95.

Plesnila N, Friedrich D, Eriskat J, Baethmann A, Stoffel M. Relative cerebral blood flow during the secondary expansion of a cortical lesion in rats. Neurosci Lett. 2003;345(2):85–8.PubMed

96.

Armstead WM. Brain injury impairs ATP-sensitive K⁺ channel function in piglet cerebral arteries. Stroke. 1997;28(11):2273–9. discussion 80.PubMed

97.

Kontos HA, Wei EP. Endothelium-dependent responses after experimental brain injury. J Neurotrauma. 1992;9(4):349–54.PubMed

98.

Ueda Y, Walker SA, Povlishock JT. Perivascular nerve damage in the cerebral circulation following traumatic brain injury. Acta Neuropathol. 2006;112(1):85–94. doi:10.1007/s00401-005-0029-5.PubMed

99.

Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol. 2002;88(3):227–49.PubMed

100.

Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci. 2000;20(18):7037–42.PubMed

101.

Zhang H, Adwanikar H, Werb Z, Noble-Haeusslein LJ. Matrix metalloproteinases and neurotrauma: evolving roles in injury and reparative processes. Neuroscientist. 2010;16(2):156–70. doi:10.1177/1073858409355830.PubMedCentralPubMed

102.

Sifringer M, Stefovska V, Zentner I, Hansen B, Stepulak A, Knaute C, et al. The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol Dis. 2007;25(3):526–35. doi:10.1016/j.nbd.2006.10.019.PubMed

103.

Roberts DJ, Jenne CN, Leger C, Kramer AH, Gallagher CN, Todd S, et al. A prospective evaluation of the temporal matrix metalloproteinase response after severe traumatic brain injury in humans. J Neurotrauma. 2013. doi:10.1089/neu.2012.2841.

104.

Suehiro E, Fujisawa H, Akimura T, Ishihara H, Kajiwara K, Kato S, et al. Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. J Neurotrauma. 2004;21(12):1706–11. doi:10.1089/neu.2004.21.1706.PubMed

105.

Beaumont A, Fatouros P, Gennarelli T, Corwin F, Marmarou A. Bolus tracer delivery measured by MRI confirms edema without blood–brain barrier permeability in diffuse traumatic brain injury. Acta Neurochir Suppl. 2006;96:171–4.PubMed

106.

Nag S, Venugopalan R, Stewart DJ. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood–brain barrier breakdown. Acta Neuropathol. 2007;114(5):459–69. doi:10.1007/s00401-007-0274-x.PubMed

107.

Pierre K, Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem. 2005;94(1):1–14.PubMed

108.

Prins ML, Giza CC. Induction of monocarboxylate transporter 2 expression and ketone transport following traumatic brain injury in juvenile and adult rats. Dev Neurosci. 2006;28(4–5):447–56.PubMed

109.

Appelberg KS, Hovda DA, Prins ML. The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat. J Neurotrauma. 2009;26(4):497–506. doi:10.1089/neu.2008.0664.PubMedCentralPubMed

110.

Wei EP, Hamm RJ, Baranova AI, Povlishock JT. The long-term microvascular and behavioral consequences of experimental traumatic brain injury after hypothermic intervention. J Neurotrauma. 2009;26(4):527–37. doi:10.1089/neu.2008.0797.PubMedCentralPubMed

111.

Abrahamson EE, Foley LM, Dekosky ST, Kevin Hitchens T, Ho C, Kochanek PM, et al. Cerebral blood flow changes after brain injury in human amyloid-beta knock-in mice. J Cereb Blood Flow Metab. 2013;33(6):826–33. doi:10.1038/jcbfm.2013.24.PubMed

112.

Neuwelt E, Abbott NJ, Abrey L, Banks WA, Blakley B, Davis T, et al. Strategies to advance translational research into brain barriers. Lancet Neurol. 2008;7(1):84–96. doi:10.1016/S1474-4422(07)70326-5.PubMed

113.

Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci. 2011;12(3):169–82. doi:10.1038/nrn2995.PubMedCentralPubMed

114.

Strbian D, Durukan A, Pitkonen M, Marinkovic I, Tatlisumak E, Pedrono E, et al. The blood–brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience. 2008;153(1):175–81.PubMed

115.

Pop V, Sorensen DW, Kamper JE, Ajao DO, Murphy MP, Head E, et al. Early brain injury alters the blood–brain barrier phenotype in parallel with beta-amyloid and cognitive changes in adulthood. J Cereb Blood Flow Metab. 2013;33(2):205–14. doi:10.1038/jcbfm.2012.154.PubMedCentralPubMed

116.

Lin JL, Huang YH, Shen YC, Huang HC, Liu PH. Ascorbic acid prevents blood–brain barrier disruption and sensory deficit caused by sustained compression of primary somatosensory cortex. J Cereb Blood Flow Metab. 2010;30(6):1121–36. doi:10.1038/jcbfm.2009.277.PubMedCentralPubMed

117.

Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, et al. P-glycoprotein deficiency at the blood–brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest. 2005;115(11):3285–90. doi:10.1172/JCI25247.PubMedCentralPubMed

118.

Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science. 2010;330(6012):1774. doi:10.1126/science.1197623.PubMedCentralPubMed

119.

Zlokovic BV. Neurodegeneration and the neurovascular unit. Nat Med. 2010;16(12):1370–1. doi:10.1038/nm1210-1370.PubMed

120.

Jodoin J, Demeule M, Fenart L, Cecchelli R, Farmer S, Linton KJ, et al. P-glycoprotein in blood–brain barrier endothelial cells: interaction and oligomerization with caveolins. J Neurochem. 2003;87(4):1010–23.PubMed

121.

Predescu D, Palade GE. Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am J Physiol. 1993;265(2 Pt 2):H725–33.PubMed

122.

Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol. 1994;4(7):231–5.PubMed

123.

Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med. 2000;6(12):1362–7. doi:10.1038/82176.PubMed

124.

Bauer PM, Yu J, Chen Y, Hickey R, Bernatchez PN, Looft-Wilson R, et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci U S A. 2005;102(1):204–9. doi:10.1073/pnas.0406092102.PubMedCentralPubMed

125.

Lajoie P, Goetz JG, Dennis JW, Nabi IR. Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J Cell Biol. 2009;185(3):381–5. doi:10.1083/jcb.200811059.PubMedCentralPubMed

126.

Nag S, Manias JL, Stewart DJ. Expression of endothelial phosphorylated caveolin-1 is increased in brain injury. Neuropathol Appl Neurobiol. 2009;35(4):417–26. doi:10.1111/j.1365-2990.2008.01009.x.PubMed

127.

McCaffrey G, Staatz WD, Quigley CA, Nametz N, Seelbach MJ, Campos CR, et al. Tight junctions contain oligomeric protein assembly critical for maintaining blood–brain barrier integrity in vivo. J Neurochem. 2007;103(6):2540–55. doi:10.1111/j.1471-4159.2007.04943.x.PubMed

128.

McCaffrey G, Staatz WD, Sanchez-Covarrubias L, Finch JD, Demarco K, Laracuente ML, et al. P-glycoprotein trafficking at the blood–brain barrier altered by peripheral inflammatory hyperalgesia. J Neurochem. 2012;122(5):962–75. doi:10.1111/j.1471-4159.2012.07831.x.PubMed

129.

Mellergard P, Sjogren F, Hillman J. Release of VEGF and FGF in the extracellular space following severe subarachnoidal haemorrhage or traumatic head injury in humans. Br J Neurosurg. 2010;24(3):261–7. doi:10.3109/02688690903521605.PubMed

130.

Morgan R, Kreipke CW, Roberts G, Bagchi M, Rafols JA. Neovascularization following traumatic brain injury: possible evidence for both angiogenesis and vasculogenesis. Neurol Res. 2007;29(4):375–81. doi:10.1179/016164107X204693.PubMed

Titel: Vascular Neural Network Phenotypic Transformation After Traumatic Injury: Potential Role in Long-Term Sequelae
verfasst von: J. Badaut
G. J. Bix
Publikationsdatum: 01.06.2014
Verlag: Springer US
Erschienen in: Translational Stroke Research / Ausgabe 3/2014
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-013-0304-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Clinically Relevant Reperfusion in Acute Ischemic Stroke: MTT Performs Better than Tmax and TTP

Catheter Placement for Lysis of Spontaneous Intracerebral Hematomas: Is a Navigated Stylet Better Than Pointer-Guided Frameless Stereotaxy for Intrahematomal Catheter Positioning?

Alzheimer’s Silent Partner: Cerebral Amyloid Angiopathy

Vascular Smooth Muscle Cells in Cerebral Aneurysm Pathogenesis

Smooth Muscle Phenotype Switching in Blast Traumatic Brain Injury-Induced Cerebral Vasospasm